Tirzepatide begins to work immediately by suppressing appetite, modulating insulin, and slowing gastric emptying
Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies
A5: Yes, consulting with a healthcare professional can help you determine the best approach for your individual health needs and goals
In the TRIUMPH-1 Phase 3 trial, participants on the 12 mg dose lost an average of 28.3% of their body weight at 80 weeks, and up to 30.3% at 104 weeks in the study extension
By activating both GLP-1 and GIP receptors, Mounjaro works on multiple pathways involved in appetite and metabolism
This may happen as the body adjusts to the medication, appetite decreases, and calorie intake drops